UBS Group’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-53,648
| Closed | -$813K | – | 8800 |
|
|
2019
Q4 | $813K | Sell |
53,648
-170,497
| -76% | -$1.47M | ﹤0.01% | 4406 |
|
|
2019
Q3 | $1.43M | Sell |
224,145
-480,768
| -68% | -$4.01M | ﹤0.01% | 3641 |
|
|
2019
Q2 | $6.74M | Buy |
704,913
+704,813
| +704,813% | +$7.59M | ﹤0.01% | 2093 |
|
|
2019
Q1 | $1K | Sell |
100
-2,993
| -97% | -$25K | ﹤0.01% | 7625 |
|
|
2018
Q4 | $23K | Buy |
3,093
+2,993
| +2,993% | +$32.7K | ﹤0.01% | 6691 |
|
|
2018
Q3 | $1K | Sell |
100
-4,886
| -98% | -$49.3K | ﹤0.01% | 7899 |
|
|
2018
Q2 | $45K | Buy |
4,986
+2,916
| +141% | +$27.2K | ﹤0.01% | 6069 |
|
|
2018
Q1 | $17K | Sell |
2,070
-71,055
| -97% | -$1.55M | ﹤0.01% | 6533 |
|
|
2017
Q4 | $2.03M | Buy |
73,125
+72,825
| +24,275% | +$1.93M | ﹤0.01% | 3186 |
|
|
2017
Q3 | $8K | Sell |
300
-1,115
| -79% | -$29.2K | ﹤0.01% | 7029 |
|
|
2017
Q2 | $41K | Buy |
1,415
+742
| +110% | +$22.6K | ﹤0.01% | 5806 |
|
|
2017
Q1 | $23K | Buy |
+673
| New | +$21.7K | ﹤0.01% | 6053 |
|
|
2016
Q4 | – | Sell |
-79
| Closed | -$3K | – | 8199 |
|
|
2016
Q3 | $3K | Buy |
79
+25
| +46% | +$805 | ﹤0.01% | 7337 |
|
|
2016
Q2 | $2K | Buy |
+54
| New | +$1.49K | ﹤0.01% | 7473 |
|
|
2015
Q4 | – | Sell |
-285
| Closed | -$7K | – | 8693 |
|
|
2015
Q3 | $7K | Buy |
285
+18
| +7% | +$437 | ﹤0.01% | 7536 |
|
|
2015
Q2 | $5K | Sell |
267
-1,446
| -84% | -$22.3K | ﹤0.01% | 7902 |
|
|
2015
Q1 | $26K | Buy |
1,713
+945
| +123% | +$15.9K | ﹤0.01% | 6711 |
|
|
2014
Q4 | $14K | Buy |
+768
| New | +$12.8K | ﹤0.01% | 8102 |
|
UBS Group's DERM Position: Q1 2020 in Review
UBS Group sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 53,648 shares — an estimated $813K sold.
UBS Group first reported a position in DERM in Q4 2014 and held it in 18 quarters. The position peaked at $6.74M in Q2 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- UBS Group reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- UBS Group sold 53,648 Dermira, Inc. shares in Q1 2020, an estimated $813K.
- UBS Group first reported a position in Dermira, Inc. in Q4 2014 and held it in 18 quarters.
- UBS Group's Dermira, Inc. position peaked at $6.74M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on UBS Group's 13F filing for Q1 2020, filed 1 May 2020.